Phase II Trial of Carboplatin and Pemetrexed +/- OGX-427 in Untreated Stage IV Non-Squamous-Non-Small-Cell Lung Cancer
Status:
Completed
Trial end date:
2017-04-19
Target enrollment:
Participant gender:
Summary
This randomized phase II study will compare the efficacy and safety of the combination of
carboplatin and pemetrexed with and without OGX-427 in patients with previously untreated
advanced non-squamous NSCLC.